Business
Warrant Exercise Notice and Total Voting Rights
Warrant Exercise Notice and Total Voting Rights.
About this update from Skinbiotherapeutics Plc
[{"type":"text","content":"\n\n3 April 2025\n \nSkinBioTherapeutics plc\n(\"SkinBioTherapeutics\" or \"the Company\")\n \n \nWarrant Exercise Notice and Total Voting Rights\n \nSkinBioTherapeutics plc, (AIM: SBTX, or the \"Company\"), the life science business focused on skin health, announces that it received an Exercise Notice from Macquarie (\"Macquarie\") for 1,000,000 ordinary shares in SkinBioTherapeutics plc at £0.2043 per share.\n \nFollowing the above exercise, the remaining warrants outstanding with Macquarie are 1,099,244 warrants.\n \n \nAdmission and Total Voting Rights\n \nApplication has been made for the 1,000,000 new ordinary shares, which will rank pari passu in all respects with the existing ordinary shares of the Company, to be admitted to AIM, which is expected to occur on or around 8.00 a.m. on 8 April 2025 (\"Admission\"). Upon Admission, the total number of issued shares and the total number of voting rights in the Company will be 232,975,383.\n \nThe above figure of 232,975,383 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\n \n-Ends-\nThe information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.\n \n \n \n \nFor more information please contact:\n \n\n\n\n\nSkinBioTherapeutics plc\nStuart J. Ashman, CEO\nManprit Randhawa, CFO\n \n \n\n\nTel: +44 (0) 191 495 7325\n \n \n \n\n\n\n\nCavendish Capital Markets Limited\n(Nominated Adviser & Broker)\nGiles Balleny, Dan Hodkinson (Corporate Finance)\nCharlie Combe (Broking)\nDale Bellis, Tamar Cranford-Smith (Sales)\n \n \n\n\nTel: +44 (0) 20 7220 0500\n\n\n\n\nVigo Consulting (financial press)\nRozi Morris\n\n\nTel: +44 (0) 20 7390 0230\[email protected] \n\n\n\n\n \n \n \nAbout SkinBioTherapeutics plc\nSkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made ...